From Name

From Email

To Name

To Email

Message

What We Know — and Don't Know — about Assessing Nonculprit Lesions After STEMI

from Cardiovascular Business

What We Know — and Don't Know — about Assessing Nonculprit Lesions After STEMI Cardiovascular Business The complete revascularization (CR) of nonculprit lesions (NCLs) after ST-segment elevation myocardial infarction (STEMI) leads to better outcomes, according to a series of recent clinical trials. But how should NCLs be evaluated? And when is the ideal time for CR to occur? READ MORE

more